首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >In Vitro Activities of Tigecycline against Erythromycin-Resistant Streptococcus pyogenes and Streptococcus agalactiae: Mechanisms of Macrolide and Tetracycline Resistance
【2h】

In Vitro Activities of Tigecycline against Erythromycin-Resistant Streptococcus pyogenes and Streptococcus agalactiae: Mechanisms of Macrolide and Tetracycline Resistance

机译:Tigecycline的抗红霉素抗性化脓性链球菌和无乳链球菌的体外活性:大环内酯和四环素抗性的机制。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The activity of tigecycline was tested against erythromycin-resistant streptococci (107 Streptococcus pyogenes and 98 Streptococcus agalactiae strains). The presence of erythromycin and tetracycline resistance genes was determined by PCR. Among S. pyogenes strains the most prevalent gene was mef(A) (91.6%). The erm(B) gene was the most prevalent (65.3%) among S. agalactiae strains. Tigecycline proved to be very active against all the isolates tested (MIC at which 90% of the isolates tested were inhibited, 0.06 μg/ml), including those resistant to tetracycline.
机译:测试了替加环素对抗红霉素的链球菌(107个化脓性链球菌和98个无乳链球菌菌株)的活性。通过PCR确定红霉素和四环素抗性基因的存在。化脓链球菌菌株中最流行的基因是mef(A)(91.6%)。在无乳链球菌菌株中,erm(B)基因最为普遍(65.3%)。事实证明,替加环素对所有测试菌株(MIC抑制率为90%,0.06μg/ ml)均具有很高的活性,其中包括对四环素具有抗性的菌株。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号